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Abundance of conserved CRISPR-Cas9 target sites
within the highly polymorphic genomes of
Anopheles and Aedes mosquitoes
Hanno Schmidt 1, Travis C. Collier1, Mark J. Hanemaaijer1,2, Parker D. Houston 1, Yoosook Lee1 &
Gregory C. Lanzaro 1✉
A number of recent papers report that standing genetic variation in natural populations
includes ubiquitous polymorphisms within target sites for Cas9-based gene drive (CGD) and
that these “drive resistant alleles” (DRA) preclude the successful application of CGD for
managing these populations. Here we report the results of a survey of 1280 genomes of the
mosquitoes Anopheles gambiae, An. coluzzii, and Aedes aegypti in which we determine that
~90% of all protein-encoding CGD target genes in natural populations include at least one
target site with no DRAs at a frequency of ≥1.0%. We conclude that the abundance of
conserved target sites in mosquito genomes and the inherent flexibility in CGD design
obviates the concern that DRAs present in the standing genetic variation of mosquito
populations will be detrimental to the deployment of this technology for population mod-
ification strategies.
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The discovery of clustered regularly interspaced shortpalindromic repeats (CRISPR) in bacteria1,2 and the Cas9enzyme (CRISPR associated protein 9)3–5, has revolutio-
nized our capacity to genetically engineer a wide range of
organisms. The subsequent development of CRISPR-Cas9-based
gene drives6 has further increased the potential application of this
technology. Gene drives promote the spread of introduced genetic
elements (e.g., alternative alleles, exogenous genes) through
populations by altering the way in which they are inherited, such
that the desired genetic element is over-represented among pro-
geny (“Super-Mendelian inheritance”)7. This leads to an increase
in frequency of the introduced genetic element, potentially until
fixation in the targeted population.
One application of CRISPR-Cas9 gene drive that has gained a
great deal of attention is the possibility of controlling populations
of disease vectors like mosquitoes. The focus of current efforts is
Anopheles gambiae and An. coluzzii which transmit malaria, and
Aedes aegypti which transmits dengue, chikungunya, yellow fever,
and Zika. Collectively, these diseases cause hundreds of thousands
of human deaths per year8. New strategies for controlling these
vectors are sorely needed because currently available control
methods are costly, increasingly ineffective due to insecticide
resistance9 and are generally difficult to deploy in rural endemic
areas. Alternative genetic-based strategies for vector control are
not new, however, the recent advances in genetic engineering and
gene drive have sparked increased interest in this approach. There
are two broad categories of strategies involving genetically engi-
neered mosquitoes (GEM) with gene drive currently under
development: population suppression aimed at greatly reducing
or eliminating the mosquito population10 and population mod-
ification, which renders mosquitoes incapable of transmitting a
pathogen but otherwise leaves it unaltered11. Recently, CRISPR-
Cas9-based gene drive systems have been designed for population
modification in Anopheles12 and Aedes13 and for population
suppression in Anopheles10,14 mosquitoes.
Experiments demonstrating the capacity of gene-drive con-
structs to spread through wild-type populations in laboratory
cages have yielded promising results10. A major limitation of
these experiments is that they use populations of mosquitoes
derived from long-standing laboratory colonies that do not
replicate populations as they occur in nature15,16. Specifically,
founder effects during establishment, repeated bottlenecks
experienced during maintenance, and selection for adaptation to
the laboratory environment in these colonies all result in the loss
of genetic variability relative to their counterparts in nature17–19.
Recently, several population genomic studies have amassed a
large volume of genomic data from natural populations of An.
gambiae20,21, An. coluzzii21, and Ae. aegypti22. These surveys
revealed exceptionally high levels of genetic variability leading
some authors to warn that CRISPR-Cas9-based gene-drive sys-
tems (CGD) may be prone to failure due to drive resistance
resulting from standing genetic variation. This includes unclea-
vable alleles within the target sequence that are not recognized by
the guide RNA21,23. A study of the impact of drive resistance
alleles (DRAs) on the performance of CGD in natural populations
of the flour beetle, Tribolium castaneum, concluded that
population-specific rare alleles will probably reduce or eliminate
drive efficacy24. General modeling approaches revealed that
standing genetic variation could even exceed de novo mutations
in contributing to CGD resistance25. Given the interest in the
development of CGD, a systematic evaluation of the distribution
of polymorphisms within the genomes of these critical mosquito
species and its impact on potential target sites for CRISPR-Cas9
editing is warranted.
Here we present genome-wide screens of the three principal
human disease vector species An. gambiae, An. coluzzii, and Ae.
aegypti for the presence of CRISPR-Cas9 target sites and an
analysis of the degree of polymorphism therein. In detail, we
search all transcribed regions of protein-coding genes in the
species’ reference genomes for potential CRISPR-Cas9 target sites.
We then subject each target site to a screen for nucleotide poly-
morphisms (single nucleotide polymorphisms, insertions, dele-
tions) in the genomes of mosquitoes sampled directly from
natural populations. Our analyses include 111 An. gambiae, 100
An. coluzzii, and 132 Ae. aegypti genomes from our lab plus
publicly available polymorphism data from 937 additional An.
gambiae s.l. samples. The special interest in An. gambiae as the
principal vector of malaria in Africa results in a larger number of
individual mosquito sequence data compared with any other
mosquito species. Additional insights gained from including the
larger number of sequences compared with An. coluzzii and Ae.
aegypti outweigh the benefits of having equal numbers per spe-
cies. We find that >30% of protein-coding genes have potential
CRISPR-Cas9 targets with GC content between 30 and 70% and
no off-target sequence. This drops to 8.4% if sites with DRAs at
frequencies >1% in natural populations are excluded. Nonetheless
~90% of all protein-coding genes contain at least one target site
that remain after this filtering. Based on these observations we
conclude that DRAs within the standing variation that exists in
natural populations of the mosquito species studied will not pose
a problem to the successful deployment of CRISPR-Cas9-based
gene drive for population modification strategies. Gene drive used
as part of population suppression strategies are more likely to be
unsustainable because of the presence of low-frequency DRAs
and the fact that they impose much stronger selection
favoring them.
Results
Identifying potential CRISPR-Cas9 target sites. We began our
analysis by identifying all potential CRISPR-Cas9 guide RNA
(gRNA) target sites in each species’ genomes and subjecting each
to an analysis to identify DRAs. We define potential target sites as
23 bp stretches with the nucleotides ‘NGG’ at one 3′-end (NGG
= protospacer adjacent motif, PAM), located in a transcript of a
protein-coding gene. To make the analysis more conservative, we
restricted our search to target sites with a GC content between 30
and 70% and no close (<4 mismatches) sequence matching
anywhere else in the genome that could produce off-target
activity. The total number of potential target sites was estimated
by screening the latest versions of the publicly available reference
genomes of An. gambiae (AgamP4) and Ae. aegypti (AaegL4)
using the program CHOPCHOP26–28. The AgamP4 genome is
sequenced from an An. gambiae–An. coluzzii-hybrid laboratory
strain and is suitable as a reference for both, An. coluzzii and An.
gambiae29.
We identified 1,196,509 high-quality potential targets in the
genome of An. gambiae s.l. and 828,454 for Ae. aegypti (Table 1).
While 69.5% (An. gambiae s.l.) and 77.2% (Ae. aegypti) of the raw
target sites were dismissed during quality filtering, the over-
whelming majority of coding genes contain at least one potential
CRISPR-Cas9 target site (97.2% in An. gambiae s.l. and 92.2% in
Ae. aegypti, Fig. 1).
DRA frequencies in natural mosquito populations. We con-
ducted screening of potential target sites for DRAs using five
unfiltered datasets of nucleotide polymorphisms from natural
mosquito populations (Table 2) from our lab (Vector Genetics
Laboratory; VGL) and The Anopheles gambiae 1000 Genomes
Consortium (Ag1000G). The nucleotide diversity (π) of tran-
scripts in protein-coding genes was between 0.94 and 1.02%
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(Table 2, Supplementary Table 1). For comparison, a relatively
high estimate of human nucleotide diversity is 0.6%30.
DRA frequencies and abundance of good CRISPR-Cas9 tar-
gets. We define a “good” CRISPR-Cas9 target site as a potential
target which contains no DRAs above a predefined DRA
threshold frequency. Sample size limits our ability to detect DRAs
below a certain frequency. If we set the threshold frequency at
0.00 the proportion of good targets is highly dependent on sample
size, with an ordinary least-squares coefficient of determination
(r2) of 0.99 (Fig. 2, orange bars). However, setting the DRA
threshold at 0.01 essentially eliminates this sampling effect (r2 of
0.00) If this threshold (<1%) is applied to all five datasets we find
~90% of protein-coding genes contain at least one good target
(Fig. 2, blue bars).
The relationship between the DRA threshold frequency and the
percentage of genes containing at least one good target is
illustrated in detail for the Ag1000G An. gambiae dataset (N=
654) (Fig. 3). The chance that any specific target site will be free of
DRAs is much lower than the chance that a given gene will
contain at least one good target. Only 28.2% of specific targets are
free from DRAs with ≥1% frequency, dropping to 6.3% for
variants with a frequency of 0.15%. Less than 3% of potential
targets are completely free of observed DRAs.
The fraction of protein-coding genes containing at least one
good target is largely independent of the DRA frequency
threshold down to a threshold of ~1%, at which point it drops
steeply (Fig. 3, blue line). For example, 91.6% of protein-coding
genes contain a good target, with no DRAs at frequencies ≥1%.
However, only 58.5% of protein-coding genes contain at least one
good target when the DRA threshold is set at 0.15%. The fraction
of good targets among all potential targets is far more sensitive to
the DRA frequency threshold, declining steadily as the DRA
frequency threshold is decreased (Fig. 3, orange line).
Discussion
In this study we confirm what has been widely reported that
mosquitoes in the genera Aedes and Anopheles have genomes that
are highly polymorphic21,22. The suggestion that standing genetic
variation will render Cas9-based gene drives ineffective in natural
mosquito populations seems to be plausible. Indeed, <3% of
potential high-quality Cas9 targets are free from any observed
variation and increasing the sample size analyzed will only reduce
this value. However, protein-coding genes almost always contain
many potential targets. The median number of potential targets
per coding gene for An. gambiae and An. coluzzii is 72 and for Ae.
aegypti it is 47. Even if there is only a 3% chance that any indi-
vidual target will be a good target, with 72 options the chance that
at least one will be good is 89% (Fig. 1). Consequently, our
analyses show that ~90% of all protein-coding genes have con-
served target sites for CRISPR-Cas9 editing in all three species
examined. The broad similarity of results between the two Ano-
pheles species and Ae. aegypti, which has quite different genomic
characteristics, suggests the observed pattern represents a general
principle. This could be tested in the future by examining
population genomic data from additional species.
Table 1 Target sites for CRISPR-Cas9 editing in mosquito
genomes.
Anopheles gambiae s.l.
(AgamP4.11)
Aedes aegypti
(AaegL5.1)
Genome size (Mbp) 230.5 1195
Coding part of the
genome (Mbp)
25.7 (11.2%) 59.1 (5%)
Raw targets 3,918,579 3,638,628
Potential targets 1,196,509 (30.5%) 828,454 (22.8%)
Protein-coding genes 12,562 13,601
Protein-coding genes with
potential targets
12,213 (97.2%) 12,536 (92.2%)
Raw targets are all unique target sites suitable for CRISPR-Cas9 editing found in transcripts of
protein-coding genes. Potential targets refer to sites that passed filtering for off-target effects
and GC content. The same reference genome (AgamP4.11) was used for A. gambiae and A.
coluzzii.
Mbp mega base pairs.
Table 2 Effect of polymorphisms on potential targets.
An. gambiae VGL An. gambiae Ag1000G An. coluzzii VGL An. coluzzii Ag1000G Ae. aegypti VGL
Samples 111 654 100 283 132
Nucleotide diversity (π) in transcribed
regions of protein-coding genes
0.98% 1.02% 1% 0.95% 0.94%
Good targets (% of raw targets/% of
potential targets)
216,793 (5.5%/18.1%) 34,995 (0.9%/2.9%) 174,117 (4.4%/14.6%) 93,142 (2.4%/7.8%) 273,627 (7.5%/33%)
Protein-coding genes with good targets, i.e.,
no variation at all (% of all protein-
coding genes)
11,163 (88.9%) 4281 (34.1%) 10,832 (86.2%) 8796 (70%) 12,536 (87.5%)
Protein-coding genes with good targets, i.e.,
no variation at frequencies ≥1% (% of all
protein-coding genes)
11,721 (93.3%) 11,525 (91.3%) 11,415 (90.9%) 11,540 (91.9%) 12,096 (88.9%)
The variant data comprises unfiltered calls for the three mosquito species. Sequence data was taken from the UC Davis Vector Genetics Lab archive. We also included publicly available variant data for
An. gambiae and An. coluzzii from the Ag1000G project. Good target sites are potential target sites that have been additionally filtered for variant data, i.e., target sites that are suitable for gene editing
with a high probability of showing no resistance alleles in natural populations.
Genome-wide 
count
After specificity 
filtering
After DRA
filtering (<1%)
CRISPR-Cas9
targets
Protein-coding
genes
100% 30.5% 8.4%
100% 97.2% 91.6%
Fig. 1 Sketch of the effect of quality filtering on the number of “good”
targets/genes. Genome-wide count of CRISPR-Cas9 targets (orange) and
protein-coding genes (blue) is set to 100% each. During specificity filtering
(GC content between 30 and 70% and no off-targets) and DRA filtering
(DRA frequency <1%), the number of available targets drops well below
10% (Table 2). Nevertheless, ~90% of all protein-coding genes still contain
at least one good target. Colored areas correspond to the values for the
combined data of An. gambiae and An. coluzzii. The percentages are similar
for Ae. aegypti (not shown). Source data are provided as a Source Data file.
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These results have implications for evaluating the prospects of
population modification versus population suppression strategies.
GEMs for population suppression are designed to eliminate fertile
females from a target population and so transgenic individuals
obviously have extremely low fitness31. Very strong selection
favoring a wild-type genotype may be to some extent countered
by the self-replicating gene drive. However, every individual with
a genotype that includes a DRA will be subjected to strong
positive selection. Therefore, even low-frequency DRAs (includ-
ing private nucleotide polymorphisms) pose a high risk to
population suppression strategies, since DRAs would rapidly
increase in frequency32,33. This translates to establishing a DRA
threshold near zero. As we demonstrate here, this will reduce the
number of protein-coding genes that are useful candidates for
genetic engineering (Fig. 3), especially in large natural popula-
tions as depicted by the sample size dependence in fraction of
genes with targets having no polymorphisms at all (Fig. 2). A
scenario where this might be useful is the targeting of small,
defined populations, where spillover to neighboring populations
is unwanted and can be avoided by the intended use of alleles that
are fixed in the target population but absent in the neighbor
population34,35. While this can also be applied with population
modification strategies, these also can be specifically designed to
have a negligible fitness cost relative to wild-type12. In this case,
low frequency wild-type genotypes that include a DRA should not
affect the gene drive behavior detrimentally, since they would
likely remain at low frequencies or be eliminated by drift36. Even
highly efficient gene-drive systems generate DRAs at frequencies
of ~1%, thus choosing this value as a threshold for standing
variation is justified from the point of view that such a level of
DRAs would have only marginal effects of inherent gene-drive
performance.
When seeking to design a GEM with CGD for release into a
natural population, researchers will most likely consider target
sites excluded by the stringent filtering applied in this study. For
example, we did not apply quality filtering of polymorphic sites in
order to be as conservative as possible. In the planning of a GEM
design study, researchers would clearly make an effort to exclude
false positive calls, thereby reducing the total number/density of
DRAs. Also, a single polymorphic site distant from the PAM (e.g.,
>−10 bp from PAM) is not expected to have dramatic effects on
cleavage efficiencies. Moreover, different nucleotide positions in
CRISPR-Cas9 target sites have quite unequal effects on cleava-
bility24,37. In summary, when evaluating a specific candidate gene
for GEM design, a much larger number of target sites for CRISPR-
Cas9 editing could be considered for empirical evaluation.
The extensive amount of data analyzed for three of the most
important human disease vector species in large parts of their
distributional area present an unprecedented view of the feasi-
bility of CRISPR-Cas9-based gene drives in mosquitoes. The
results demonstrate that good target sites lacking DRAs or with
DRAs present at low frequency are abundant in the three species
studied. The abundance of good target sites in mosquito genomes
and the inherent flexibility in CRISPR-Cas9-based gene-drive
design suggests that drive resistance arising from selection on
standing genetic variation will not be a detriment to the
deployment of this technology for eliminating mosquito-borne
diseases.
Methods
Search for potential CRISPR-Cas9 target sites. Potential CRISPR-Cas9 target
sites were searched with the command line version of CHOPCHOP
v6054ae8b29b926–28 with Python v.2.7.1538, applying default settings and
‘Xu_2015’ efficiency scoring39. We modified CHOPCHOP slightly to fix a minor
bug in the handling of chromosome names and to increase the maximum target
(transcript) size. We restricted the search to the transcripts (coding sequences+
untranslated regions) of protein-coding genes from the most recent annotation files
downloaded from vectorbase.org, with 12,562 entries for protein-coding genes in
An. gambiae (AgamP4.11) and 13,601 for Ae. aegypti (AaegL5.1). The output was
filtered for targets that show no off-target sites with less than four mismatches to
the original sequence and that have a GC content between 30 and 70%. We denote
CRISPR-Cas9 target sites that passed this procedure as “potential target sites”.
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Fig. 2 Frequency of genes with good targets. The fraction of genes with
good targets is dependent on the presence of low-frequency DRAs. When
dismissing all targets with DRA frequencies > 0.0, the fraction of genes
with good targets decreases with increasing sample size. Ignoring DRAs
with frequencies below 1% in the dataset results in ~90% of genes having
at least one good target in all datasets examined. VGL: Vector Genetics
Laboratory, Ag1000G: The Anopheles gambiae 1000 Genomes Consortium.
Source data are provided as a Source Data file.
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Fig. 3 Effects of polymorphisms on targets. Percent of genes containing at
least one good target (blue) and percent of good targets out of possible targets
as a function of DRA frequency threshold (orange). This analysis is based on
N= 654 An. gambiae samples (Ag1000G data). DRA frequency threshold is
the value beyond which alternative alleles are considered to be DRAs and are
filtered out (i.e., a DRA frequency threshold of 0.01 means, alternative alleles
with a frequency below 1% are ignored during filtering). Note the constant
decline in the fraction of good targets (orange), which is not mirrored in the
fraction of genes containing good targets (blue) until the DRA frequency
threshold is set at <0.01. Source data are provided as a Source Data file.
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Anopheles gambiae s.l. data preparation. We used individual whole genome
sequencing data from N= 111 An. gambiae s.s. samples from natural populations
in Mali (N= 40), Cameroon (N= 5), Tanzania (N= 6), Zambia (N= 6), and the
Comoro Islands (N= 54) and N= 100 An. coluzzii samples from natural popu-
lations in Mali (N= 66), Benin (N= 11), Equatorial Guinea (N= 3), Cameroon
(N= 1), and São Tomé and Príncipe (N= 19). Specimens for sequencing were
taken from the Vector Genetics Laboratory’s archive (Supplementary Data 1).
Genomic DNA was sequenced on an Illumina HiSeq 4000 to a mean depth of
10.2X (Supplementary Table 2). Sequences were filtered for adapters with Trim-
momatic v0.3640 and then mapped against the most current reference genome
assembly ‘AgamP4’41 using BWA MEM v0.7.17-r118842. Polymorphic sites were
called with Freebayes v1.2.043 applying default parameters but ‘theta=0.01’ and
‘max-complex-gap=3′.
The Ag1000G datasets were processed by MalariaGen (www.malariagen.net)
using BWA-MEM mapping and GATK UnifiedGenotyper44 workflow45.
Aedes aegypti data preparation. We used individual whole genome data from N
= 132 Ae. aegypti samples from California (N= 122), Florida (N= 4), Mexico (N
= 3), and South Africa (N= 3) from the Vector Genetics Laboratory’s archive
(Supplementary Data 1) sequenced to a mean depth of 10.5X (Supplementary
Table 2). Sequences were generated and data were processed in the same way as
described above for Anopheles samples, using the most current reference genome
assembly ‘AaegL5’46.
Polymorphisms in potential CRISPR-Cas9 target sites. We did not include any
subsequent quality filtering of detected polymorphisms to ensure having the broadest
possible set of potential polymorphic sites and hence being as conservative as pos-
sible (i.e., removing all doubtful/undecidable potential CRISPR-Cas9 target sites).
The potential CRISPR-Cas9 target sites were then filtered for polymorphic sites using
custom scripts available at https://github.com/travc/Cas9_target_site_survey.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequence data sources are detailed in Supplemental Table S1. Data processing scripts and
small datafiles are available in GitHub with the identifier: [https://doi.org/10.5281/
zenodo.3661448]47. Any additional data that support the findings of this study are
available from the corresponding author upon reasonable request.
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